US FDA approves Pfizer's RSV vaccine

The Pfizer logo is pictured on their headquarters building in the Manhattan borough of New York City, New York, U.S., November 9, 2020. REUTERS/Carlo Allegri/File Photorespiratory syncytial virus vaccine for older adults, making it the second shot against the common respiratory disease that can be fatal for seniors.. Pfizer's vaccine was approved for people aged 60 and older, the company said, the same age group as GSK's shot.

The CDC's advisory committee is expected to meet in June to discuss the vaccines, including who should receive them and how often. If the vaccine is recommended by the CDC for routine use, it will be widely available at no out-of-pocket cost for most older Americans covered by the government Medicare health plan, the company said.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA issues warning about some compounded versions of semaglutide for diabetes, weight loss | CNNThe US Food and Drug Administration issued a warning Tuesday about compounded versions of the drug semaglutide, which is approved for treatment of diabetes and excess weight.
Source: CNN - 🏆 4. / 95 Read more »